FBI (US Federal Bureau of Investigation) takes documents from Medi-Hut premises:
This article was originally published in Clinica
Executive Summary
Medi-Hut, the Lakewood, New Jersey-based maker of safety syringes, says the US Federal Bureau of Investigation removed documents and computers from its headquarters after obtaining a search warrant. The company says it has "not been advised of the nature of the US Government's investigation". Meanwhile, Medi-Hut's move to new headquarters should be completed by December 2. This summer the US Securities and Exchange Commission launched an investigation into Medi-Hut's financial disclosures and internal accounting controls (see Clinica No 1015, p 18).
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.